WCK-4034

N/A

Report date: 2022/06/22 17:54:37
NME

Base Information

Drug NameWCK-4034
Drug Alias NameWCK-4034
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsInfluenza, HumanPneumococcal InfectionsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWockhardt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, HumanPneumococcal InfectionsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A